Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07045883

Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss

Mechanism and Clinical Application of Vitamin D in Influencing the Prognosis of Idiopathic Sudden Sensorineural Hearing Loss

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
197 (estimated)
Sponsor
Zhongshan Hospital Xiamen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Clinical Trial Protocol: Investigating the Therapeutic Efficacy of Vitamin D in ISSNHL。Core Research Questions Can vitamin D supplementation improve the prognosis of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)? What potential medical issues might arise during vitamin D administration? Study Design A controlled trial comparing: Intervention group: Vitamin D supplementation + standard care Control group: Standard care alone Participant Procedures Baseline assessment: Venous blood draw (2 mL) for 25(OH)D level measurement. intervention phase:Daily vitamin D supplementation for 1 month Endpoint evaluation (1-month follow-up): Repeat audiometric testing (pure-tone audiometry). Post-treatment 25(OH)D concentration analysis.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D Supplementation+ standard treatmentThe experimental group was tested for 25(OH)D concentration after enrollment, and the experimental group was divided into vitamin D deficiency group and vitamin D normal group. In the vitamin D-deficient group, participants will receive standard treatment plus oral vitamin D3 supplementation (800 IU daily for 4 weeks), whereas the vitamin D normal group will receive standard treatment alone
OTHERstandard treatmentThe experimental group was tested for 25(OH)D concentration after enrollment, and the experimental group was divided into vitamin D deficiency group and vitamin D normal group. The vitamin D normal group will receive standard treatment alone

Timeline

Start date
2025-06-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2025-07-01
Last updated
2025-07-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07045883. Inclusion in this directory is not an endorsement.